AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2012
Nov 9, 2012
29745_dirs_2012-11-09_d6c955a6-225c-420f-b999-cd6f9b1b8d8b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2012-11-01
Reporting Person: Zakrowski Donald A (Chief Accounting Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2772 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee stock option 2/03 (right to buy) | $57.85 | 2013-02-15 | Common Stock (500) | Direct | |
| Employee stock option 2/04 (right to buy) | $73.11 | 2014-02-14 | Common Stock (600) | Direct | |
| Restricted Stock Unit | $ | 2012-12-03 | Common Stock (1641) | Direct | |
| Restricted Stock Unit | $ | 2017-12-03 | Common Stock (3281) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29